UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) shares were up 0.6% on Monday . The company traded as high as $504.51 and last traded at $503.32. Approximately 1,044,554 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 4,102,520 shares. The stock had previously closed at $500.13.
Wall Street Analysts Forecast Growth
UNH has been the topic of several recent research reports. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Stephens increased their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Finally, Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $626.84.
View Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Stock Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.66%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.
Institutional Trading of UnitedHealth Group
Several institutional investors and hedge funds have recently bought and sold shares of the company. Delta Financial Group Inc. boosted its stake in UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after buying an additional 17 shares during the period. GoalVest Advisory LLC grew its holdings in shares of UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 18 shares in the last quarter. Fiduciary Group LLC raised its stake in UnitedHealth Group by 0.5% in the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after purchasing an additional 18 shares in the last quarter. First PREMIER Bank grew its position in UnitedHealth Group by 7.0% in the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 18 shares in the last quarter. Finally, Genesee Capital Advisors LLC raised its position in UnitedHealth Group by 1.9% during the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- What is the Dow Jones Industrial Average (DJIA)?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is the Dogs of the Dow Strategy? Overview and Examples
- 2 Drone Stocks Surging from Increased Media Attention
- Technology Stocks Explained: Here’s What to Know About Tech
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.